Predictors of kidney-related outcomes in chronic heart failure patients with concomitant type 2 diabetes mellitus treated with dapagliflozin
| dc.contributor.author | Berezin, A. E. | |
| dc.contributor.author | Fushtey, I. M. | |
| dc.contributor.author | Berezina, T. A. | |
| dc.contributor.author | Obradovic, Z. | |
| dc.contributor.author | Berezin, O. O. | |
| dc.contributor.author | Hoppe, U. | |
| dc.contributor.author | Lichtenauer, M. | |
| dc.contributor.author | Фуштей, Іван Михайлович | |
| dc.date.accessioned | 2025-05-13T07:37:11Z | |
| dc.date.available | 2025-05-13T07:37:11Z | |
| dc.date.issued | 2024 | |
| dc.identifier.citation | Predictors of kidney-related outcomes in chronic heart failure patients with concomitant type 2 diabetes mellitus treated with dapagliflozin / A. E. Berezin, I. M. Fushtey, T. A. Berezina, Z. Obradovic, O. O. Berezin, U. Hoppe, M. Lichtenauer // European Journal of Heart Failure. - 2024. - Vol. 26, Suppl. S2. - P. 170-171. | uk_UK |
| dc.identifier.uri | https://zsmu.rosbai.com/handle/123456789/22560 | |
| dc.language.iso | en | uk_UK |
| dc.subject | тези доповідей | uk_UK |
| dc.title | Predictors of kidney-related outcomes in chronic heart failure patients with concomitant type 2 diabetes mellitus treated with dapagliflozin | uk_UK |
| dc.type | Other | uk_UK |